#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians need reliable patient education resources about cannabinoid hyperemesis syndrome, a condition that may be underdiagnosed or misattributed to other causes as cannabis use becomes more prevalent. YouTube videos are among the most accessed health information sources, making their accuracy critical for patient understanding and treatment compliance. This assessment of video quality directly impacts what patients learn about symptom recognition and the evidence-based management strategy of cannabis cessation.
This study examined the quality and accuracy of YouTube content addressing cannabinoid hyperemesis syndrome (CHS), a hyperemesis condition associated with heavy cannabis use that clinicians increasingly encounter in practice. As cannabis legalization expands, patients and the public increasingly rely on online video platforms for health information, yet the quality and medical accuracy of such content remains poorly regulated and variable. The researchers assessed videos for educational value, medical accuracy, and adherence to evidence-based information about CHS pathophysiology, clinical presentation, and management. Given that many patients may encounter misleading or incomplete information online before presenting to clinical care, understanding the information landscape is important for clinicians counseling patients about cannabis risks and managing suspected CHS cases. Clinicians should be prepared to discuss CHS with informed patients who may have encountered inaccurate online sources and should recognize that public health messaging about cannabis-related adverse effects remains fragmented across media platforms. Healthcare providers should actively educate patients about reliable sources of cannabis safety information while remaining alert to CHS in patients with persistent nausea and vomiting associated with regular cannabis use.
“When patients come to me having self-diagnosed cannabinoid hyperemesis syndrome from YouTube videos, I find they’ve often confused cannabis hyperemesis with other treatable conditions or missed the critical dose-response relationship that actually matters clinically. The problem isn’t that CHS exists, it does, but that online information lacks the nuance to help patients understand when cannabis is truly contraindicated versus when dose adjustment or cannabinoid profile changes could resolve their symptoms.”
💊 As cannabinoid hyperemesis syndrome (CHS) becomes an increasingly recognized clinical entity alongside rising cannabis potency and use prevalence, the quality and accuracy of patient-facing information sources deserves scrutiny. This analysis of YouTube content highlights a critical gap: many patients and families seeking to understand CHS symptoms and management may encounter misleading or incomplete information online, potentially delaying appropriate diagnosis and contributing to unnecessary emergency department visits. Healthcare providers should be aware that patients presenting with recurrent nausea, vomiting, and compulsive hot bathing may arrive with preconceptions shaped by low-quality digital sources, and may benefit from explicit discussion of CHS as part of cannabis use screening. The complexity lies in balancing cannabis’s potential therapeutic applications for other conditions against the real risk of CHS in susceptible users, particularly given individual variation in cannabinoid metabolism and exposure patterns. Clinically, providers should routinely counsel cannabis users about CHS
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
